论文部分内容阅读
曾名噪一时且耗费巨资(超过2亿元人民币)建成的清华紫光延庆药业基地在沉寂了一年之后,于2001年底开始运转,且更名为北京清华紫光制药厂。 一位业内人士告诉记者,这个药业基地前后共投进了资金2亿多元人民币,其建设规模和所投资金在国内均处于前列。可是一直没有投入生产,从建成之日起整个厂区处于荒废状态,造成了很大的资源和资金的浪费。现在整个工厂的运营和人员工资主要靠湖南古汉生物制药股份有限公司来承担。 这么先进的药业基地为什么在建成后沉寂这么长时间才复出?作为投资者这是不是—个重大失误?现在情况是不是象该业内人士所述等等,带着一系列问题本刊记者对位于八达岭经济技术开发区的北京清华紫光制药厂进行了实地探访,并走访了清华紫光集团的有关人士。
Everlasting and costly (more than 200 million yuan) built Qinghua Ziguang Yanqing pharmaceutical base in silence for a year later, by the end of 2001 and renamed the Beijing Qinghua Ziguang Pharmaceutical Factory. An industry source told reporters that before and after the pharmaceutical base invested a total of more than 200 million yuan of funds, its construction scale and investment in the country are in the forefront. But has not been put into production, from the date of completion of the entire plant in a waste state, resulting in a great waste of resources and funds. Now the entire operation of the factory and staff salaries mainly rely on Hunan Guhan Biological Pharmaceutical Co., Ltd. to undertake. Why is such an advanced pharmaceutical base quiet after the completion of such a long time to come back? As an investor this is not a major mistake? Now the situation is not as the industry insiders, etc., with a series of questions correspondents Tsinghua Unisplendour Pharmaceutical Factory, located in Badaling Economic and Technological Development Zone, conducted a field visit and visited the relevant parties of Tsinghua Unisplendour Group.